PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New study provides breakthrough in pig-to-human kidney transplantation

A pioneering study has provided unprecedented insights into the immune response following pig-to-human kidney xenotransplantation.

2025-06-29
(Press-News.org) (Monday 30 June 2025, London, United Kingdom) A pioneering study has provided unprecedented insights into the immune response following pig-to-human kidney xenotransplantation.1

The findings, presented today at the ESOT Congress 2025, mark a significant step forward in overcoming the biggest challenge in xenotransplantation: rejection by the human immune system.

Using cutting-edge spatial molecular imaging, researchers mapped how human immune cells interact with pig kidney tissue in transplanted organs, revealing critical early markers of rejection and potential intervention strategies. The study, led by Dr. Valentin Goutaudier and a collaborative international research team (Paris Institute for Transplantation and Organ Regeneration & NYU Langone Transplant Institute), highlights key molecular mechanisms that could shape the future of xenotransplantation.

One of the most striking discoveries was that human immune cells were found in every part of the pig kidney's filtering system after the transplant. Researchers observed early molecular signs of antibody-mediated rejection as soon as Day 10 and peaking at Day 33, reinforcing previous findings that rejection begins rapidly but progresses over time.2 By tracking these immune responses for up to 61 days, the team identified a crucial window for targeted therapeutic intervention.

“Our study provides the most detailed molecular map to date of how the human immune system engages with a transplanted pig kidney,” explained Dr. Goutaudier. “By pinpointing specific immune cell behaviours and gene expressions, we can refine anti-rejection treatments and improve transplant viability.”

The study’s innovative approach used a bioinformatic pipeline to distinguish human immune cells from pig structural cells, allowing for precise mapping of immune infiltration patterns. Notably, macrophages and myeloid cells were the most prevalent immune cell types across all time points, further confirming their role as key mediators in xenograft rejection.

When targeted therapeutic interventions were introduced, immune-mediated signs of rejection were successfully weakened. Combined with novel spatial insights into how immune cells interact with pig kidney tissue, this marks a major breakthrough — paving the way for more refined anti-rejection strategies. These advances come at a pivotal time as the first US-based clinical trials of pig kidney transplantation into living human recipients begin in 2025.

With xenotransplantation poised to address the global organ shortage crisis, these findings bring researchers one step closer to making genetically modified pig kidneys a viable long-term solution. The next phase will focus on optimising anti-rejection treatments, refining genetic modifications in donor pigs, and developing early detection protocols to monitor and manage rejection responses.

“Understanding the specific immune interactions at a molecular level allows us to develop targeted interventions that can prevent rejection before it escalates,” explained Dr. Goutaudier. “This research lays the groundwork for safer and more effective pig-to-human transplants in the near future.”

As scientific progress accelerates, researchers remain cautiously optimistic that genetically modified pig kidneys could become a routine transplant option within the next decade. However, regulatory approvals will require consistent demonstration of safety and efficacy in diverse patient populations.

 

END

 

Note to editors:

A reference to the ESOT Congress 2025 must be included in all coverage and/or articles associated with this study.

For more information or to arrange an expert interview, please contact Luke Paskins on press@esot.org.

About the study author:

Dr. Valentin Goutaudier is a researcher in transplant immunology and xenotransplantation, affiliated with the Paris Institute for Transplantation and Organ Regeneration (PITOR) and Inserm U970. His work focuses on understanding immune responses in allo- and xenotransplantation, utilising advanced molecular imaging and bioinformatics to develop targeted anti-rejection therapies. The PITOR work on kidney xenotransplantation is performed in collaboration with the NYU Langone Transplant Institute led by Prof. Robert A. Montgomery.

About ESOT:

The European Society for Organ Transplantation (ESOT) was founded 40 years ago and is dedicated to the pursuit of excellence in organ transplantation. Facilitating a wealth of international clinical trials and research collaborations over the years, ESOT remains committed to its primary aim of improving patient outcomes in transplantation. With a community of over 8000 members from around the world, ESOT is an influential international organisation and the facilitator of the biennial congress which hosts approximately 3500 experts who come to meet to explore and discuss the latest scientific research.

References:

Goutaudier V., Williams, C., Morgand, E., et al.  Application of a Novel Spatial Transcriptomic 6000-Plex Panel in Pig-to-Human Xenotransplantation. Presented at ESOT Congress 2025; 30th June 2025; London, United Kingdom. Loupy, A., Goutaudier, V., Giarraputo, A. et al. (2023). Immune response after pig-to-human kidney xenotransplantation: A multimodal phenotyping study. The Lancet, 402(10408), 1158–1169. https://doi.org/10.1016/S0140-6736(23)01855-3 Montgomery RA, Stern JM, Lonze BE, Tatapudi VS, Mangiola M, Wu M, Weldon E, Lawson N, Deterville C, Dieter RA, Sullivan B, Boulton G, Parent B, Piper G, Sommer P, Cawthon S, Duggan E, Ayares D, Dandro A, Fazio-Kroll A, Kokkinaki M, Burdorf L, Lorber M, Boeke JD, Pass H, Keating B, Griesemer A, Ali NM, Mehta SA, Stewart ZA. Results of Two Cases of Pig-to-Human Kidney Xenotransplantation. N Engl J Med. 2022 May 19;386(20):1889-1898. doi: 10.1056/NEJMoa2120238. PMID: 35584156. END



ELSE PRESS RELEASES FROM THIS DATE:

Gut bacteria and amino acid imbalance linked to higher miscarriage risk in women with PCOS

2025-06-29
(Paris, France, Monday, 30 June 2025) A new study presented today at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) reveals that women with polycystic ovary syndrome (PCOS) have distinct gut microbiota and metabolic signatures linked to premature endometrial ageing and a higher risk of adverse pregnancy outcomes.[1]  The research highlights a sharp reduction in the beneficial gut bacterium Parabacteroides merdae (P. merdae), alongside elevated levels of branched-chain amino ...

Simple blood test detects preeclampsia risk months before symptoms appear, new study shows

2025-06-29
(Paris, France, Monday, 30 June 2025) A simple blood test taken in the first trimester of pregnancy could accurately identify women at risk of developing preeclampsia five months before clinical diagnosis, according to new research presented today at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE).[1] Using a cell-free RNA (cfRNA) “liquid biopsy” of maternal plasma, researchers at the Carlos Simon Foundation and iPremom enrolled 9,586 pregnant women from 14 hospitals across Spain between September 2021 and June 2024. In a nested case-control analysis of 216 participants, they successfully predicted both early-onset and late-onset ...

3D printing breakthrough: Scientists create functional human islets for type 1 diabetes treatment

2025-06-28
(Monday, 30 June 2025, London, United Kingdom) A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink. Presented today at the ESOT Congress 2025, the new technology could pave the way for more effective and less invasive treatment options for people living with type 1 diabetes (T1D).1 The breakthrough involved printing human islets – the insulin-producing clusters of cells in the pancreas – using a customised bioink made from alginate and decellularised human pancreatic tissue. This approach produced durable, high-density islet structures that remained alive and functional ...

Malnutrition in children rises when economy drops

2025-06-27
Even small drops in national income can significantly increase the risk of various forms of childhood malnutrition- not only undernutrition but also overweight and obesity, shows a study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa” Foundation. The study, published in Lancet Global Health, identifies pregnancy and the first 1,000 days of life as especially vulnerable periods where targeted interventions can make a big difference. One in four children worldwide lives in severe food poverty. And many low- and middle-income countries ...

New model enables the study of how protein complex influences mitochondrial function

2025-06-27
A study by the Center for Redox Processes in Biomedicine (Redoxoma) led by Marilene Demasi from the Butantan Institute (São Paulo, Brazil) presents a valuable new experimental model for investigating the interaction between the proteasome and mitochondrial function. In eukaryotic cells, the proteasome is a protein complex responsible for eliminating damaged and nonfunctional proteins, thereby helping to maintain cellular balance and proper functioning. In recent years, studies have revealed that the proteasome ...

Device study offers hopes for spinal cord injuries

2025-06-27
Spinal cord injuries are currently incurable with devastating effects on people’s lives, but now a trial at Waipapa Taumata Rau, University of Auckland offers hope for an effective treatment. Spinal cord injuries shatter the signal between the brain and body, often resulting in a loss of function.“Unlike a cut on the skin, which typically heals on its own, the spinal cord does not regenerate effectively, making these injuries devastating and currently incurable,” says lead researcher Dr Bruce Harland, a senior research fellow in the School of Pharmacy at Waipapa Taumata Rau, University of Auckland. Before birth, and to a lesser extent afterwards, ...

How urea forms spontaneously

2025-06-27
Urea is one of the most important industrial chemicals produced worldwide. It is used as a fertiliser, for the production of synthetic resins and explosives and as a fuel additive for cleaning car exhaust gases. Urea is also believed to be a potential key building block for the formation of biological molecules such as RNA and DNA in connection with the question of the origin of life (see ETH News from 28 June 2023). Until now, the origin of urea itself on Early Earth has not been conclusively clarified. A research team led by Ruth Signorell, Professor of Physical Chemistry ...

Mayo Clinic’s AI tool identifies 9 dementia types, including Alzheimer’s, with one scan

2025-06-27
ROCHESTER, Minn. — Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single, widely available scan — a transformative advance in early, accurate diagnosis.  The tool, StateViewer, helped researchers identify the dementia type in 88% of cases, according to research published online on June 27, 2025, in Neurology, the medical journal of the American Academy of Neurology. It also enabled clinicians to interpret brain scans ...

Gene therapy improves blood flow in the brain in patients with sickle cell disease

2025-06-27
(MEMPHIS, Tenn. – June 27, 2025) Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new study from St. Jude Children’s Research Hospital. Many people with sickle cell disease experience increased brain ischemia, where oxygen is not delivered properly to brain tissues, potentially leading to strokes. A part of the risk for these events comes from increased blood flow speed in the brain. Findings from three patients in a gene therapy clinical trial showed ...

Building breast tissue in the lab to better understand lactation

2025-06-27
Human breast milk is uniquely adapted to meet an infant’s nutritional needs. Surprisingly, we still know very little about how milk is even made in the breast. A team of ETH Zurich researchers led by Marcy Zenobi-Wong, Professor of Tissue Engineering and Biofabrication, want to change that. In the lab, Zenobi-Wong and her team developed tiny replicas of lactating breast tissue. This involved isolating cells from human breast milk that are naturally found in milk. Some of the cells from lactating breast tissue and the so-called lactocytes – the cells in breast tissue that produce milk – end up in ...

LAST 30 PRESS RELEASES:

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

Blocking protein control pathway slows rhabdomyosarcoma growth in mice

2026 Hertz Fellowship Application Now Open

[Press-News.org] New study provides breakthrough in pig-to-human kidney transplantation
A pioneering study has provided unprecedented insights into the immune response following pig-to-human kidney xenotransplantation.